The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward - Wikidata - wikimedia - TriplyDB

The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward

The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward

http://www.wikidata.org/entity/Q33834072

about

Estimating and mapping the population at risk of sleeping sickness The quality of methods reporting in parasitology experiments Escaping Deleterious Immune Response in Their Hosts: Lessons from Trypanosomatids Overview of the Diagnostic Methods Used in the Field for Human African Trypanosomiasis: What Could Change in the Next Years?The ever unfolding story of cAMP signaling in trypanosomatids: vive la difference!A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis Contemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei gambiense: review A literature review of economic evaluations for a neglected tropical disease: human African trypanosomiasis ("sleeping sickness")Drug repurposing and human parasitic protozoan diseases Trypanocidal activity of marine natural products Human African trypanosomiasis in non-endemic countries (2000-2010)Glossina fuscipes populations provide insights for human African trypanosomiasis transmission in Uganda Epidemiology of human African trypanosomiasis Implications of Heterogeneous Biting Exposure and Animal Hosts on Trypanosomiasis brucei gambiense Transmission and Control A Novel Allosteric Inhibitor of the Uridine Diphosphate N -Acetylglucosamine Pyrophosphorylase from Trypanosoma brucei Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase Structural basis for trypanosomal haem acquisition and susceptibility to the host innate immune system Cell cycle regulation and novel structural features of thymidine kinase, an essential enzyme in Trypanosoma brucei A Multi-Host Agent-Based Model for a Zoonotic, Vector-Borne Disease. A Case Study on Trypanosomiasis in Eastern Province, Zambia Wolbachia symbiont infections induce strong cytoplasmic incompatibility in the tsetse fly Glossina morsitans Pharmacology of DB844, an orally active aza analogue of pafuramidine, in a monkey model of second stage human African trypanosomiasis In-silico investigation of antitrypanosomal phytochemicals from Nigerian medicinal plants Modeling the control of trypanosomiasis using trypanocides or insecticide-treated livestock Agrochemicals against malaria, sleeping sickness, leishmaniasis and Chagas disease Cathepsin-L can resist lysis by human serum in Trypanosoma brucei brucei Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo Efficacy, Safety, and Dose of Pafuramidine, a New Oral Drug for Treatment of First Stage Sleeping Sickness, in a Phase 2a Clinical Study and Phase 2b Randomized Clinical Studies Genome-Wide Comparative Analysis of Chemosensory Gene Families in Five Tsetse Fly Species Quantifying Heterogeneity in Host-Vector Contact: Tsetse (Glossina swynnertoni and G. pallidipes) Host Choice in Serengeti National Park, Tanzania Global christianity and the control of its neglected tropical diseases Global Profiling and Inhibition of Protein Lipidation in Vector and Host Stages of the Sleeping Sickness Parasite Trypanosoma brucei Community acceptance of tsetse control baits: a qualitative study in Arua District, North West Uganda Adult blood-feeding tsetse flies, trypanosomes, microbiota and the fluctuating environment in sub-Saharan Africa.Comparative SILAC proteomic analysis of Trypanosoma brucei bloodstream and procyclic lifecycle stages.Genetic diversity and population structure of the tsetse fly Glossina fuscipes fuscipes (Diptera: Glossinidae) in Northern Uganda: Implications for vector control Pharmacokinetic comparison to determine the mechanisms underlying the differential efficacies of cationic diamidines against first- and second-stage human African trypanosomiasis.In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness Sleeping sickness in travelers - do they really sleep?International glossina genome initiative 2004-2014: a driver for post-genomic era research on the African continent Actigraphy in human African trypanosomiasis as a tool for objective clinical evaluation and monitoring: a pilot study

P2860

Q21092278-A1F25397-771F-483A-99CE-9826E9AD4A17 Q24288682-C573483A-2B37-4BED-B7BE-D2D21718B5D0 Q26745974-02EBBC2B-6989-418A-AD33-9D1687FE85FD Q26778571-53C00140-DB97-443C-BA4B-C316B308DD80 Q26781588-56C39A8A-4F88-477F-B04A-98B6467470BF Q26820381-E9E5DA6D-59CD-48BE-9D92-757A0495602F Q26825682-C60F90FE-82A7-4036-B71C-CC2F506235E7 Q26826895-38893022-A08E-48AC-B0E1-0422267054D5 Q26999453-69C6B8C0-7090-4298-B718-C3254946514C Q27008593-95540076-A045-4835-905F-FD317EEB297A Q27008972-E77B033E-2453-4FF3-A2FE-4C33AAB1BC87 Q27012611-A304B781-174E-4EC2-AE44-EF85EDEA90DF Q27026504-50952104-11B2-4D59-AE35-247E55E6B234 Q27317424-00F266B5-4D4F-4742-A562-09F620AAAE4D Q27678978-2D7B4EF0-FBBF-4F8F-8143-90C261977F62 Q27690137-055729FC-C332-49D2-B939-79519BEAC993 Q27696195-674641BB-9C67-4D81-A472-F003B419F464 Q27720126-77FE4D9E-F2EB-4521-A5C2-C97A7796422D Q28469366-1CD697C6-D502-41F5-85EE-9DAA162B7AED Q28478312-D43507F4-0DA9-42D9-8878-2378646A3C2B Q28481509-7E0B6077-432A-49D3-9A26-BDC4202CD4A1 Q28481512-411F97F1-8884-44DF-BB40-ED13D581C37F Q28483695-200B97C7-F6D7-4831-8935-FA16F6177BCE Q28484975-34DA9292-A5B1-456B-A2B8-3765A0C51341 Q28538908-320ABD65-A3BD-4AD0-93B8-02B945C28DEE Q28543489-9DDED963-1CC8-4E02-8282-CDB3E601EDA0 Q28550224-AD0304D9-5127-4603-96C4-7AC9B427D781 Q28550234-D7988B42-7D78-46E1-AD8C-A4D45861122F Q28597928-BEE52CE3-E6B8-4D02-AA63-D73B14CDF7D9 Q28651694-1E740DB2-B4BB-40D2-9AF4-C4079B4DD121 Q28830468-8D0887A3-5916-42EA-A1A3-0000E732CAE3 Q30392667-7B1F7DE4-BCCE-4306-A94D-3583B5310422 Q30877850-846C9FCB-6CBC-4487-8FE8-6B4142090282 Q31061421-41E682AC-ECD4-4370-92F6-83C5139FFC62 Q33657997-6774C073-4F50-419F-8834-CAB88A254081 Q33798222-9BF743FF-1738-416E-B286-9C03B698DCBA Q34058294-4A734947-0E01-4BD8-A483-F2AD21FD0B24 Q34070616-ADA9BF4A-F02F-4B38-A212-45378F013AF4 Q34075145-FE460944-8D8B-4238-8D43-E5CC3F929D59 Q34163935-BEC01B19-0D93-48A9-A57D-EAB6D2DEC0EA

P2860

The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward

http://www.wikidata.org/entity/Q33834072

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

The human African trypanosomia ...... ion 2000-2009: the way forward

@ast

The human African trypanosomia ...... ion 2000-2009: the way forward

@en

type

label

The human African trypanosomia ...... ion 2000-2009: the way forward

@ast

The human African trypanosomia ...... ion 2000-2009: the way forward

@en

prefLabel

The human African trypanosomia ...... ion 2000-2009: the way forward

@ast

The human African trypanosomia ...... ion 2000-2009: the way forward

@en

P1433

Q33834072-CDC64FB9-E562-4079-B941-A4318E345E83

P1476

Q33834072-0EF26CDA-C55D-4506-AAC2-7CD103B2C0CD

P2093

Q33834072-194D2E7A-3D6E-4A79-B650-73FC91E92FC8

Q33834072-75EC9807-E01A-4CEA-9352-777DE14F61DD

Q33834072-CAA7816F-C127-4486-B893-83986FDA14FD

Q33834072-EB52C028-1734-4FB6-A952-B11958E03E53

Q33834072-EE479A27-33A7-4757-BE99-DC57D4516AFE

P275

Q33834072-94DC637F-453B-4669-B66B-48966C1AC0FE

P2860

Q33834072-0EB23B61-FC1F-4449-80CC-D077AB04C653

Q33834072-1D9A0BB6-B887-4D4E-BDAC-7EE852B6577D

Q33834072-26822174-2F7F-4E19-AD51-44C81FF1A7DD

Q33834072-30EB2C47-1934-4505-AF7E-385F601AA65B

Q33834072-39269BA4-AC5D-462D-8B00-7FC87F17E575

Q33834072-417395CA-F87E-4731-A598-90FE4E74D9D7

Q33834072-42DB37E2-8CEE-4B0A-80FE-AD8A5E96F372

Q33834072-50773AE3-6253-41AE-A3BA-C87BEB487EA8

Q33834072-53C6A105-554A-461A-8DA4-F77257BE0E05

Q33834072-55B68E05-5C75-4618-9C55-902BC6825313

P304

Q33834072-4D171B81-5D88-4D0C-96F0-8EA04D041AFF

P31

Q33834072-B0F78139-AB9F-4CDE-A3B3-9A7090517688

P356

Q33834072-68A90064-7982-426E-911A-3D706741E7D1

P407

Q33834072-6C07C9D0-B843-4708-84C4-A3BCF5E6961C

P433

Q33834072-07579C51-FBE5-409F-B20E-BBCE4663471F

P478

Q33834072-F06381D3-2E78-4059-87CF-C7200FE9BB78

P5008

Q33834072-33DE287F-C5B4-47BB-AF44-1FF9D1949190

P577

Q33834072-824AF4EA-EED4-4535-92E3-481CE8CB66EC

P5875

Q33834072-D9FF5B96-2F3C-4941-9E40-3EDCA15501BA

P698

Q33834072-5EEB19D5-3AFA-4638-9046-488915060F60

P921

Q33834072-0164C9A3-3F0C-40EB-B206-86A486C34663

Q33834072-248384D4-48E1-4B6F-B2B9-9B57C30F0EA6

Q33834072-D17D3741-1510-44B8-BB31-1AE02B14634E

P932

Q33834072-0AAF2395-8EA9-433D-9C8A-E3B59A29FF3D

P356

JOURNAL.PNTD.0001007

P1433

PLOS Neglected Tropical Diseases

P1476

The human African trypanosomia ...... ion 2000-2009: the way forward

@en

P2093

Abdoulaye Diarra

http://www.w3.org/2001/XMLSchema#string

Jean G Jannin

http://www.w3.org/2001/XMLSchema#string

Jose A Ruiz Postigo

http://www.w3.org/2001/XMLSchema#string

José R Franco

http://www.w3.org/2001/XMLSchema#string

Pere P Simarro

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire

Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness

Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda

Nifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case series

Mapping sleeping sickness in Western Africa in a context of demographic transition and climate change.

The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases

Waking up to sleeping sickness.

Sleeping sickness in West Africa (1906-2006): changes in spatial repartition and lessons from the past.

The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda.

P304

e1007

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PNTD.0001007

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2011-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50250889

http://www.w3.org/2001/XMLSchema#string

P698

21364972

http://www.w3.org/2001/XMLSchema#string

P921

African trypanosomiasis

trypanosomiasis

Alþjóðaheilbrigðismálastofnunin

P932

3042999

http://www.w3.org/2001/XMLSchema#string